ResMed Inc. (RMD)
Pre-market:
| Previous close | 233.98 |
| Open | 234.67 |
| Bid | 0.00 x 1800 |
| Ask | 0.00 x 800 |
| Day's range | 230.44 - 236.54 |
| 52-week range | 132.24 - 255.18 |
| Volume | |
| Avg. volume | 999,307 |
| Market cap | 34.092B |
| Beta (5Y monthly) | 0.69 |
| PE ratio (TTM) | 33.57 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 2.12 (0.91%) |
| Ex-dividend date | 15 Aug 2024 |
| 1y target est | N/A |
- GlobeNewswire
ResMed to Report First Quarter Fiscal 2025 Earnings on October 24, 2024
SAN DIEGO, Oct. 03, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the first quarter of fiscal year 2025 on Thursday, October 24, 2024, after the New York Stock Exchange closes. Following the release, ResMed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast. Earnings webcast details: Location: http://investor.resmed.com Date
- GlobeNewswire
ResMed Unveils 2030 Strategy to Drive Growth, Profitability, and Shareholder Returns
2030 ambition to help more than 500 million people worldwide achieve their full health potentialShowcases integration of intelligent products and solutions within the ResMed ecosystem, designed to deliver a better experience, lower costs, and enhanced outcomes for patients and providersIntroduces updated five-year financial outlook NEW YORK and SAN DIEGO, Sept. 30, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today unveiled its 2030 Strategy to drive growth, profitability, and sharehold
- GlobeNewswire
UPDATE -- ResMed Unveils New Collection of Digital and Personalized Solutions designed to Improve Sleep Health
Dawn Dawn myAir MyAir LUXE LUXE ResMed makes it easier for people to manage their sleep health and stay on (continuous positive airway pressure) CPAP treatment by integrating its leading myAir™ consumer app with Apple and Android smartwatches. Introduces a Generative AI-enabled sleep health assistant to guide people on their journey to better sleep and new travel gear to help people stay on CPAP treatment while traveling. SAN DIEGO, Sept. 30, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD)
